US Value-based Care for Medical Technology Growth Opportunities

US Value-based Care for Medical Technology Growth Opportunities

Advanced Technologies Enable Interoperable Solutions, At-home Care, and Improved Patient Experience

RELEASE DATE
01-Dec-2021
REGION
North America
Research Code: K63E-01-00-00-00
SKU: HC03480-NA-MT_26020
$4,950.00
In stock
SKU
HC03480-NA-MT_26020
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countries in Western Europe.

The geographical scope of the study will be mainly the United States. The research study will provide an overview of US value-based healthcare from the medtech industry perspective. The study will explore the underlying need and demand for VBC for the US market. New care models outside of hospital settings will effectively utilize limited hospital resources to accommodate the clinical demand from aging and chronic populations. The effective delivery of VBC requires collaboration among stakeholders like payers, providers, and medical device manufacturers. Advanced technologies will cover many more acute conditions under the hospital-at-home care model and enhance patient experiences and outcomes.

Author: Kaustubh Suresh Savant

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the United States’ (US) Value-based Care (VBC) for Medical Technology (Medtech) Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Key Questions Answered in This Study

Defining Value in the Future

Delivering on the VBC Framework

VBC to Transform the Industry’s System Structure, Payment Delivery, and Care Provision

Growth Drivers

Growth Restraints

What Keeps Hospital Chief Executive Officers (CEOs) Awake at Night

Future US Healthcare Spending is Unsustainable

US Healthcare is Expensive But Lags in Value Delivery

Statistical Alert 1—Strong Need for Optimal Healthcare Resource Utilization

Statistical Alert 2—Need to Improve Population Health and Clinical Outcomes

Wastage Saved is Value Earned ?

Challenges in New Technology Adoption

COVID-19 Impact on Hospital Margins in 2021

Strategic Imperatives Driving Outpatient Care

VBC Potential Assessment by Medical Speciality

VBC Potential Assessment by Medical Specialty—Cardiology

VBC Potential Assessment by Medical Specialty—Orthopedics

VBC Potential Assessment by Medical Specialty—Oncology

VBC Potential Assessment by Medical Specialty—Gastroenterology

VBC Potential Assessment by Medical Specialty—Neurology

VBC Potential Assessment by Medical Specialty—Nephrology

VBC Potential Assessment by Medical Specialty—Pulmonology

VBC Potential Assessment by Medical Specialty—Endocrinology

VBC to Help Transform Care Delivery

Strong Underlying Fundamentals Support Care Delivery Shifts

Care Delivery Shifts to Impact Patient Volume Dynamics

Inpatient Patient Volume Impact Analysis

Outpatient Patient Volume Impact Analysis

Trend 1—Value Drivers to Cause Steady ASC Growth

Trend 2—Accountable Care Organizations’ (ACOs) Growth to Plateau but the Future of Value-based Care to Remain Intact

Trend 3—Payer Support to Boost HaH Adoption

Trend 4—Hospitals to Focus on Post-discharge/Bridge Clinics to Reduce Readmission Rates

Trend 5—Telemedicine in Rural Hospitals

Trend 6—The Virtualization of Primary Care

Trend 7—Inclination Toward On-demand Care to Result in Surge for Urgent Care Clinics

Trend 8—COVID-19 to Accelerate the Use of Retail Clinics

Trend 9—Trends in Urgent and Retail Clinics Usage in 2019

Strategic Implications and Call to Action for Medtech Players

Supporting Regulatory and Reimbursement Policies

Supporting Regulatory and Reimbursement Policies (continued)

Supporting Regulatory and Reimbursement Policies (continued)

Supporting Regulatory and Reimbursement Policies (continued)

Future Direction—Transition toward APM and Population Health-based Plans

Strategic Implications and Call to Action for Medtech Players

Population Health Management (PHM), Central to Value-based Reimbursement, is a Difficult Business for Providers

AI and Internet of Medical Things (IoMT)—2 Major Technology Enablers for Value-based Care

The Right Care at the Right Time Through the Right Medium—A Connected IoMT

IoMT Enables the Transition of Care Delivery

IoMT Enables the Transition of Care Delivery (continued)

Digitized Data Boom—A Push Toward Predictive Care to Drive Demand for Healthcare AI Solutions

AI for Improving Workflow Efficiency and Care Delivery

Patient Data Stratification and Sources for Precision Health and PHM

Combinatorial Care Delivery Technologies to Drive Value

Combinatorial Care Delivery Technologies to Drive Value (continued)

Supporting Technologies for Care Continuum to be Mainstream

Technology Adoption to Empower Patient-centric Solutions

Strategic Implications and Call to Action for Medtech Players

Medtech Players Will Need to Account for Changing Financial Risks

Statistics for VBC Payments Indicate Divisive Adoption Among Providers

Need to Optimize the Value Analysis Approach to Procurement

Current Adoption of VBC Payment Contracts in Medtech

Strategic Implications and Call to Action for Medtech Players

Growth Opportunity 1: Developing Effective Interoperability Solutions to Address Data Gaps

Growth Opportunity 1: Developing Effective Interoperability Solutions to Address Data Gaps (continued)

Growth Opportunity 2: Designing Comprehensive Strategic Framework for Competitive Advantage

Growth Opportunity 2: Designing Comprehensive Strategic Framework for Competitive Advantage (continued)

Growth Opportunity 3: Targeting Emerging Markets for Market Expansion Options

Growth Opportunity 3: Targeting Emerging Markets for Market Expansion Options (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Legal Disclaimer

Related Research
The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countries in Western Europe. The geographical scope of the study will be mainly the United States. The research study will provide an overview of US value-based healthcare from the medtech industry perspective. The study will explore the underlying need and demand for VBC for the US market. New care models outside of hospital settings will effectively utilize limited hospital resources to accommodate the clinical demand from aging and chronic populations. The effective delivery of VBC requires collaboration among stakeholders like payers, providers, and medical device manufacturers. Advanced technologies will cover many more acute conditions under the hospital-at-home care model and enhance patient experiences and outcomes. Author: Kaustubh Suresh Savant
More Information
No Index No
Podcast No
Author Kaustubh Suresh Savant
Industries Healthcare
WIP Number K63E-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9A47-B1,9A4B-B1